Colchicine for kidney-related heart inflammation
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This Phase 2 trial tests whether colchicine can reduce inflammation and improve heart function in people with kidney disease and a certain type of heart problem. If you qualify, you’ll be closely monitored for side effects and lab changes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 21 to 80
- Have kidney function in a specific range (eGFR 15 to 75)
- Have higher-than-normal urine protein (albumin-to-creatinine ratio over 30)
- Take appropriate blood pressure/protein-protecting kidney medicines (ACE inhibitor or ARB) unless your clinician says not to
- If indicated, take an SGLT2 inhibitor (a kidney/heart medicine like empagliflozin or dapagliflozin)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether colchicine, a drug that reduces inflammation, can help prevent further heart problems or strokes in people with moderate chronic kidney disease. You may be eligible if you have kidney disease and have had a heart attack, stroke, or related event in the past.
This study tests whether a daily low dose of colchicine, a medicine used for gout and inflammation, can reduce inflammation and improve blood vessel and bone health in people with chronic kidney disease. It might help prevent complications like heart disease and weak bones.
This trial tests if the anti-inflammatory drug colchicine can help people hospitalized with acute heart failure and a weak heart pump. It may benefit those with elevated inflammation markers.
This study tests whether the drug colchicine can reduce inflammation in people with coronary heart disease who have had a stent placed. It aims to see if colchicine helps improve heart health by lowering inflammation.
This study tests whether taking a daily low dose of colchicine, a medicine used for inflammation, can help prevent a first heart attack or other heart problems in people who are at higher risk due to their risk factors. If you qualify, you would be assigned to take either colchicine or a placebo (a pill with no active medicine) to see if it helps keep your heart healthy.
This trial tests whether a low-dose colchicine (LoDoCo) can help people with heart failure and inflammation feel better and exercise more. It is for adults 50 and older with HFpEF who have signs of inflammation in their blood.
Hear when a new Chronic Kidney Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.